1. Home
  2. VIR vs UAN Comparison

VIR vs UAN Comparison

Compare VIR & UAN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VIR
  • UAN
  • Stock Information
  • Founded
  • VIR 2016
  • UAN 2007
  • Country
  • VIR United States
  • UAN United States
  • Employees
  • VIR N/A
  • UAN N/A
  • Industry
  • VIR Biotechnology: Pharmaceutical Preparations
  • UAN Agricultural Chemicals
  • Sector
  • VIR Health Care
  • UAN Industrials
  • Exchange
  • VIR Nasdaq
  • UAN Nasdaq
  • Market Cap
  • VIR 844.9M
  • UAN 773.6M
  • IPO Year
  • VIR 2019
  • UAN 2011
  • Fundamental
  • Price
  • VIR $5.30
  • UAN $82.70
  • Analyst Decision
  • VIR Strong Buy
  • UAN
  • Analyst Count
  • VIR 7
  • UAN 0
  • Target Price
  • VIR $33.57
  • UAN N/A
  • AVG Volume (30 Days)
  • VIR 1.0M
  • UAN 25.6K
  • Earning Date
  • VIR 05-07-2025
  • UAN 04-28-2025
  • Dividend Yield
  • VIR N/A
  • UAN 8.60%
  • EPS Growth
  • VIR N/A
  • UAN N/A
  • EPS
  • VIR N/A
  • UAN 7.13
  • Revenue
  • VIR $20,861,000.00
  • UAN $540,525,000.00
  • Revenue This Year
  • VIR N/A
  • UAN N/A
  • Revenue Next Year
  • VIR $10.65
  • UAN N/A
  • P/E Ratio
  • VIR N/A
  • UAN $11.58
  • Revenue Growth
  • VIR N/A
  • UAN N/A
  • 52 Week Low
  • VIR $4.95
  • UAN $62.94
  • 52 Week High
  • VIR $14.45
  • UAN $88.94
  • Technical
  • Relative Strength Index (RSI)
  • VIR 34.32
  • UAN 71.18
  • Support Level
  • VIR $5.04
  • UAN $78.25
  • Resistance Level
  • VIR $6.29
  • UAN $83.84
  • Average True Range (ATR)
  • VIR 0.29
  • UAN 1.85
  • MACD
  • VIR -0.00
  • UAN 0.64
  • Stochastic Oscillator
  • VIR 20.54
  • UAN 88.11

About VIR Vir Biotechnology Inc.

Vir Biotechnology Inc is an immunology company focused on combining cutting-edge technologies to treat and prevent serious infectious diseases and other serious conditions, including viral-associated diseases. Through internal development, collaborations, and acquisitions, it has four technology platforms, focused on antibodies, T cells, innate immunity, and small interfering ribonucleic acid, or siRNA. The company's pipeline consists of product candidates targeting hepatitis B, HBV, influenza A, human immunodeficiency virus, HIV, and tuberculosis, or TB. Its revenue sources are collaboration revenue, contract revenue, grant revenue, and license revenue.

About UAN CVR Partners LP Common Units representing Limited Partner Interests

CVR Partners LP is a manufacturer and supplier of nitrogen fertilizer products. Its principal products include Urea Ammonium Nitrate (UAN) and ammonia. The company market ammonia products to industrial and agricultural customers and UAN products to agricultural customers. The primary geographic markets for its fertilizer products are Kansas, Missouri, Nebraska, Iowa, Illinois, Colorado, and Texas. The company's product sales are heavily weighted toward UAN.

Share on Social Networks: